Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Atopic dermatitis.

Gionata Buggiani1, Federica Ricceri, Torello Lotti

  • 1Dermatology Physiotherapy Unit, University of Florence School of Medicine, Florence, Italy. gionata.buggiani@unifi.it

Dermatologic Therapy
|April 9, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Forty-eight-week safety of bimekizumab in psoriasis: focus on infectious comorbidities.

Italian journal of dermatology and venereology·2025
Same author

Therapeutic Modulation Of Peripheral Blood Cells And Inflammatory Indices During 52 Weeks Of Risankizumab In Responder Patients With Moderate-to-Severe Psoriasis: Results From A Multicenter Prospective Study.

Dermatology practical & conceptual·2025
Same author

Psoriasis severity, comorbidity burden, and biologic therapy: a multicenter observational study using the Charlson Comorbidity Index.

The Journal of dermatological treatment·2025
Same author

Risankizumab in very elderly patients in real-world practice.

Italian journal of dermatology and venereology·2024
Same author

Age affects drug survival rates of interleukin (IL)-17 and IL-23 inhibitors in patients with plaque psoriasis: Results from a retrospective, multicentric, multi-country, cohort study.

Journal of the European Academy of Dermatology and Venereology : JEADV·2024
Same author

Efficacy of risankizumab after intra-class switching between anti IL-23 antagonists: a multi-center, retrospective, real-life observation.

Italian journal of dermatology and venereology·2023
Same journal

Increased Risk of Cutaneous T-Cell Lymphoma Development after Dupilumab Use for Atopic Dermatitis.

Dermatologic therapy·2024
Same journal

Correction to "Adjuvant PD-1 inhibitor versus high-dose interferon α-2b for Chinese patients with cutaneous and acral melanoma: A retrospective cohort analysis".

Dermatologic therapy·2022
Same journal

A case of erythema nodosum concomitant with ulcerative colitis relieved by tofacitinib.

Dermatologic therapy·2022
Same journal

A case report of vitiligo following toripalimab therapy for a patient with metastatic melanoma.

Dermatologic therapy·2022
Same journal

High versus low dose oral isotretinoin in the treatment of cutaneous and genital warts.

Dermatologic therapy·2022
Same journal

Evaluation of the efficacy and relapse rates of treatment protocols for moderate acne using isotretinoin based on the global acne grading system: Randomized, controlled, comparative study.

Dermatologic therapy·2022
See all related articles

Atopic dermatitis (AD) is a common skin condition with varied presentations. Understanding its complex causes and treatment challenges is crucial for dermatologists managing this chronic disease.

Area of Science:

  • Dermatology
  • Immunology

Background:

  • Atopic dermatitis (AD) is a prevalent skin condition with diverse clinical presentations across age groups.
  • While etiologic factors and pathogenetic pathways are extensively studied, a complete understanding of AD remains elusive.
  • The chronic nature of AD and potential adverse effects of treatments pose significant management challenges.

Purpose of the Study:

  • To highlight the ongoing need for comprehensive understanding of atopic dermatitis.
  • To emphasize the complexities in treating atopic dermatitis due to its chronic course and treatment limitations.
  • To underscore the importance of informed therapeutic decisions for dermatologists.

Main Methods:

  • Literature review on atopic dermatitis etiology and pathogenesis.
  • Analysis of treatment challenges including adverse events and comorbidities.

Related Experiment Videos

  • Discussion of therapeutic modalities and clinical decision-making.

    • Main Results:

    • Atopic dermatitis exhibits varied clinical manifestations and etiologies.
    • Treatment efficacy is often limited by adverse events, intolerances, and contraindications.
    • Comorbidities can further complicate the management of atopic dermatitis.

    Conclusions:

    • Further research is needed to fully elucidate the pathogenesis of atopic dermatitis.
    • Optimizing treatment strategies requires careful consideration of individual patient factors and potential risks.
    • Dermatologists require comprehensive knowledge to effectively manage atopic dermatitis with available therapies.